Target intelligence / Profile preview

Calpain-2 (None)

Target
None
Molecular classification
Enzyme, Cysteine protease, Calcium-dependent protease, Intracellular protease
01

Overview

Calpain-2, also known as m-calpain or calcium-activated neutral protease II, is a large catalytic subunit of the calpain family—calcium-dependent, non-lysosomal cysteine proteases found in most mammalian tissues[1][6]. It typically exists as a heterodimer with the common small regulatory subunit (CAPNS1/CAPN4). Calpain-2 requires higher calcium concentrations for activation than its close paralog calpain-1 and is involved in the limited proteolysis of key structural and regulatory proteins. Its critical functions include modulation of the cytoskeleton for cell migration, cell signal transduction, apoptosis, and cell cycle events[1][3][6]. Dysregulated calpain-2 activity is implicated in various pathologies, including cancer, neurodegenerative, cardiovascular, and inflammatory diseases. While calpain inhibitors have shown preclinical efficacy as therapeutic agents, drug development is complicated by the enzyme family's ubiquitous expression, structural similarity among isoforms, and essential roles in normal physiology[4][6].

Other names
m-calpaincalpain IIcalcium-activated neutral protease IICANP2
02

Mechanism of action

Inhibition of protease activity (for inhibitors: block the catalytic cysteine in the active site) Reduction of substrate cleavage and downstream cellular effects

03

Biological functions

Cytoskeletal remodelingCell migrationSignal transductionApoptosisCell cycle regulation
04

Disease associations

CancerNeurodegenerative diseaseCardiovascular diseaseInflammation
05

Safety considerations

Potential off-target effects due to calpain isoform similarityEssential roles in normal cell physiology increase risk of toxicity with systemic inhibitionDifficulty in achieving isoform specificity for therapeutic inhibition
06

Interacting drugs

Calpeptin

2 more in the full profile.

07

Biomarkers

Calpain activity assays (used as pharmacodynamic markers in tissue/cell studies)Calpain-cleaved spectrin or other substrate fragments in disease states

Beyond the preview

Go deeper on Calpain-2 (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Calpain-2 (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call